These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2517634)

  • 21. [Apolipoproteins A and B in cerebrovascular diseases].
    Bruck J; Fischer M; Sluga E; Tschabitscher H
    Nervenarzt; 1985 Feb; 56(2):89-93. PubMed ID: 3982568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical usefulness of measuring apolipoproteins in diabetic patients: a preliminary report.
    Fachnie JD; McGill J; Foreback C; Kahkonen DM
    Henry Ford Hosp Med J; 1986; 34(2):113-6. PubMed ID: 3093407
    [No Abstract]   [Full Text] [Related]  

  • 24. The relation of apolipoproteins A-I and B in children to parental myocardial infarction.
    Freedman DS; Srinivasan SR; Shear CL; Franklin FA; Webber LS; Berenson GS
    N Engl J Med; 1986 Sep; 315(12):721-6. PubMed ID: 3092050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Apolipoprotein AI-CIII, B, and CII gene polymorphisms in patients with non-insulin dependent diabetes mellitus. Association with hyperlipemia].
    Gutiérrez C; Vendrell J; Broch M; Pastor R; Llor C; Simón I; Richart C
    Med Clin (Barc); 1996 Nov; 107(15):561-5. PubMed ID: 9064379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nephropathy on the composition of apolipoprotein-containing particles in NIDDM.
    Nagai T; Tomizawa T; Nakajima K; Uehara Y; Mori M
    J Atheroscler Thromb; 1998; 5(2):54-9. PubMed ID: 10855558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.
    Luoma PV; Marniemi J; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.
    Wolffenbuttel BH; Franken AA; Vincent HH;
    J Intern Med; 2005 Jun; 257(6):531-9. PubMed ID: 15910557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDL subparticles and coronary artery disease in NIDDM.
    O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Kottke BA
    Atherosclerosis; 1996 Apr; 121(2):285-91. PubMed ID: 9125302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma level of total cholesterol, triglycerides, HDL-C, and apolipoproteins A-I and B in normal and healthy Chinese adults].
    Mu JY; Cheung MH; Lin HF
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Apr; 41(4):255-62. PubMed ID: 3179813
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of insulin treatment on serum lipoprotein(a) in non-insulin-dependent diabetes.
    Kuusi T; Yki-Järvinen H; Kauppinen-Mäkelin R; Jauhiainen M; Ehnholm C; Kauppila M; Seppälä P; Viikari J; Kujansuu E; Rajala S
    Eur J Clin Invest; 1995 Mar; 25(3):194-200. PubMed ID: 7781667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in plasma cholesterol and apolipoprotein B levels in non-obese type 2 diabetic subjects.
    Ikeda T; Terasawa H; Ishimura M; Ochi H; Ohtani D; Fujiyama K; Hoshino T; Tanaka Y; Mashiba H
    Diabete Metab; 1992; 18(6):465-7. PubMed ID: 1297605
    [No Abstract]   [Full Text] [Related]  

  • 36. Apolipoprotein levels in non-insulin-dependent diabetes mellitus with clinical macroangiopathy.
    Ikeda T; Ohtani I; Fujiyama K; Hoshino T; Tanaka Y; Tekeuchi T; Mashiba H
    Diabete Metab; 1991; 17(3):373-8. PubMed ID: 1884882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A-I gene polymorphism and susceptibility of non-insulin-dependent diabetes mellitus.
    Buraczynska M; Hanzlik J; Grzywa M
    Am J Hum Genet; 1985 Nov; 37(6):1129-37. PubMed ID: 3936351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum lipid and apolipoprotein levels in non-hypertensive lean NIDDM patients.
    Ikeda T; Ochi H; Ohtani I; Fujiyama K; Hoshino T; Tanaka Y; Takeuchi T; Mashiba H
    J Intern Med; 1991 Aug; 230(2):131-4. PubMed ID: 1865164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Apolipoproteins and the vascular risk in hemodialyzed subjects].
    Allegra V; Mengozzi G; Spulzaro P; Piani C; Di Marco F; Vasile A
    Minerva Urol Nefrol; 1986; 38(4):435-41. PubMed ID: 3589890
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlates of atherosclerosis in coronary arteries of patients undergoing angiographic evaluation.
    Perez GO; Mendez AJ; Goldberg RB; Duncan R; Palomo A; DeMarchena E; Hsia SL
    Angiology; 1990 Jul; 41(7):525-32. PubMed ID: 2117860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.